• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊维菌素在新冠治疗中的应用现状

Current status of usage of ivermectin in the management of COVID.

作者信息

Ilangovan Swetha, Ganapathy Dhanraj, Ahmed Nabeel, Pandurangan Kiran Kumar, Maiti Subhabrata

机构信息

Department of Prosthodontics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India.

出版信息

J Adv Pharm Technol Res. 2022 Dec;13(Suppl 2):S407-S411. doi: 10.4103/japtr.japtr_344_22. Epub 2022 Dec 30.

DOI:10.4103/japtr.japtr_344_22
PMID:36798565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9926582/
Abstract

The antibacterial, antiviral, and anticancer properties of ivermectin make it a wonder drug with a wide range of possible applications. It works against a variety of microorganisms, including viruses. Ivermectin has a wide range of antiviral effects, according to research in animal models. Because ivermectin is involved in a range of biological processes, it could be a promising therapeutic candidate for viruses such as COVID-19 and other positive-sense single-stranded RNA viruses. The study aims to analyze the awareness about the current status of usage of ivermectin in management of COVID among students studying in a private dental college. A study based on questionnaire was organized among students studying in a private dental college in Tamil Nadu. The subjects were asked a series of structural questions based on the usage of ivermectin in management of COVID. The questionnaire was prepared with 10 questions. 150 individuals completed the questionnaire; all of their answers were tallied in excel and imported into SPSS. For statistical analysis, the Chi-square test was performed. Excel was used to tabulate and enter the data, and the SPSS package software was used to analyze it. The study's threshold for statistical significance was set at < 0.05. From this study, we found that the students had limited knowledge about the usage of ivermectin for management of COVID. More studies should be conducted to widen the knowledge among the students about the current affairs of the world.

摘要

伊维菌素的抗菌、抗病毒和抗癌特性使其成为一种具有广泛潜在应用的神奇药物。它对多种微生物有效,包括病毒。根据动物模型研究,伊维菌素有广泛的抗病毒作用。由于伊维菌素参与一系列生物过程,它可能是治疗新冠病毒(COVID-19)等正链单链RNA病毒的有前景的候选药物。该研究旨在分析在一所私立牙科学院就读的学生对伊维菌素在新冠治疗中使用现状的认知情况。在泰米尔纳德邦一所私立牙科学院的学生中组织了一项基于问卷的研究。根据伊维菌素在新冠治疗中的使用情况,向受试者询问了一系列结构化问题。问卷设置了10个问题。150人完成了问卷;他们所有的答案都在Excel中进行了统计,并导入到SPSS中。为进行统计分析,采用了卡方检验。使用Excel对数据进行制表和录入,使用SPSS软件包对其进行分析。该研究的统计显著性阈值设定为<0.05。通过这项研究,我们发现学生对伊维菌素用于新冠治疗的使用情况了解有限。应该进行更多研究,以拓宽学生对世界时事的了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/a67553ebdbc5/JAPTR-13-407-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/c5785ad0cb06/JAPTR-13-407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/6a5a9618a1fe/JAPTR-13-407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/c991eb183d6b/JAPTR-13-407-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/d24d90323574/JAPTR-13-407-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/a67553ebdbc5/JAPTR-13-407-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/c5785ad0cb06/JAPTR-13-407-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/6a5a9618a1fe/JAPTR-13-407-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/c991eb183d6b/JAPTR-13-407-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/d24d90323574/JAPTR-13-407-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bc2/9926582/a67553ebdbc5/JAPTR-13-407-g005.jpg

相似文献

1
Current status of usage of ivermectin in the management of COVID.伊维菌素在新冠治疗中的应用现状
J Adv Pharm Technol Res. 2022 Dec;13(Suppl 2):S407-S411. doi: 10.4103/japtr.japtr_344_22. Epub 2022 Dec 30.
2
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.伊维菌素:从抗病毒作用到 COVID-19 补充治疗方案的系统评价。
J Antibiot (Tokyo). 2020 Sep;73(9):593-602. doi: 10.1038/s41429-020-0336-z. Epub 2020 Jun 12.
3
Ivermectin in COVID-19 Management: What is the Current Evidence?伊维菌素在 COVID-19 管理中的应用:目前有哪些证据?
Infect Disord Drug Targets. 2022;22(4):e190122200367. doi: 10.2174/1871526522666220119114035.
4
Awareness on current status of usage of ritonavir in the management of covid among dental students.牙科学生对利托那韦在新冠管理中使用现状的认识。
J Adv Pharm Technol Res. 2022 Nov;13(Suppl 1):S228-S232. doi: 10.4103/japtr.japtr_345_22. Epub 2022 Nov 30.
5
Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial.随机临床试验比较伊维菌素与安慰剂对秘鲁早期 COVID-19 患者鼻咽 PCR 转阴的疗效(SAINT-Peru):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 9;22(1):262. doi: 10.1186/s13063-021-05236-2.
6
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.SARS-CoV-2 依维莫司纳瓦拉-ISGlobal 试验(SAINT)评估依维莫司在症状出现后 48 小时内降低低危、非重症 COVID-19 患者 COVID-19 传播风险的潜力:一项随机对照试验方案的研究方案结构化总结。
Trials. 2020 Jun 8;21(1):498. doi: 10.1186/s13063-020-04421-z.
7
Comparison of the Ivermectin and Lopinavir/Ritonavir Treatment Outcomes among COVID-19 Mild to Moderate Cases in Kaduna State.卡杜纳州 COVID-19 轻症和中度病例中伊维菌素和洛匹那韦/利托那韦治疗结局的比较。
West Afr J Med. 2022 Feb 28;39(2):140-146.
8
Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis.伊维菌素作为 COVID-19 附加治疗的治疗潜力:系统评价和荟萃分析。
J Pharm Pharm Sci. 2020;23:462-469. doi: 10.18433/jpps31457.
9
Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.伊维菌素预防 COVID-19 患者住院(IVERCOR-COVID19):一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Nov 24;21(1):965. doi: 10.1186/s13063-020-04813-1.
10
Assessment of Knowledge, Attitude, and Practices Regarding Advanced Local Anesthetic Techniques among Students Attending a Private Dental College in Navi Mumbai, India: A Cross-sectional Study.印度新孟买一所私立牙科学院学生对高级局部麻醉技术的知识、态度和实践评估:一项横断面研究
Int J Clin Pediatr Dent. 2022 Jan-Feb;15(1):94-98. doi: 10.5005/jp-journals-10005-2347.

本文引用的文献

1
Dentists' Preference toward Fixed Versus Removable Implant Prosthesis on Edentulous Jaws to Improve Quality of Life.牙医对无牙颌固定与可摘种植修复体的偏好以改善生活质量
J Long Term Eff Med Implants. 2022;33(1):83-89. doi: 10.1615/JLongTermEffMedImplants.2022038746.
2
Polyether ether ketone - As an alternative biomaterial for Metal Richmond crown-3-dimensional finite element analysis.聚醚醚酮——作为金属里士满冠的替代生物材料——三维有限元分析
J Conserv Dent. 2021 Nov-Dec;24(6):553-557. doi: 10.4103/jcd.jcd_638_20. Epub 2022 Apr 1.
3
Three-dimensional-Printed Malo Bridge: Digital Fixed Prosthesis for the Partially Edentulous Maxilla.
三维打印马洛桥:用于上颌部分牙列缺失的数字固定修复体
Contemp Clin Dent. 2021 Oct-Dec;12(4):451-453. doi: 10.4103/ccd.ccd_456_20. Epub 2021 Dec 21.
4
Data on dental bite materials with stability and displacement under load.关于在负载下具有稳定性和位移的牙科咬合材料的数据。
Bioinformation. 2020 Dec 31;16(12):1145-1151. doi: 10.6026/973206300161145. eCollection 2020.
5
Correlation of soft tissue biotype with pink aesthetic score in single full veneer crown.单颗全瓷贴面修复中软组织生物型与粉色美学评分的相关性
Bioinformation. 2020 Dec 31;16(12):1139-1144. doi: 10.6026/973206300161139. eCollection 2020.
6
Open- or Closed-Tray Impression Technique in Implant Prosthesis: A Dentist's Perspective.种植体修复中的开口托盘或闭口托盘印模技术:牙医的视角。
J Long Term Eff Med Implants. 2020;30(3):193-198. doi: 10.1615/JLongTermEffMedImplants.2020035933.
7
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness.一项为期五天的伊维菌素治疗 COVID-19 的疗程可能会缩短疾病的持续时间。
Int J Infect Dis. 2021 Feb;103:214-216. doi: 10.1016/j.ijid.2020.11.191. Epub 2020 Dec 2.
8
COVID-19 pathophysiology: A review.新型冠状病毒肺炎的病理生理学:综述。
Clin Immunol. 2020 Jun;215:108427. doi: 10.1016/j.clim.2020.108427. Epub 2020 Apr 20.
9
Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.单独隔离或与其他公共卫生措施相结合以控制新冠病毒病:一项快速综述
Cochrane Database Syst Rev. 2020 Apr 8;4(4):CD013574. doi: 10.1002/14651858.CD013574.
10
COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features.新型冠状病毒肺炎相关急性出血性坏死性脑病:影像学特征
Radiology. 2020 Aug;296(2):E119-E120. doi: 10.1148/radiol.2020201187. Epub 2020 Mar 31.